Open Access

18-Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis

  • Sofia Chatziioannou1, 6,
  • Odysseas Papamichos3,
  • Maria N. Gamaletsou2,
  • Alexandros Georgakopoulos6,
  • Nikolaos G. Kostomitsopoulos7,
  • Sofia Tseleni-Balafouta4,
  • Joseph Papaparaskevas5,
  • Thomas J. Walsh8,
  • Spiros G. Pneumaticos3Email author and
  • Nikolaos V. Sipsas2Email author
Journal of Orthopaedic Surgery and Research201510:132

https://doi.org/10.1186/s13018-015-0274-9

Received: 14 April 2015

Accepted: 8 August 2015

Published: 27 August 2015

Abstract

Background

18-Fluoro-2-deoxy-d-glucose positron emission tomography combined with computed tomography (18F-FDG PET/CT) scan is useful for diagnosis of osteoarticular infections. Whether 18F-FDG PET/CT scanning may be used for therapeutic monitoring is not clear. The objective of this study was to develop 18F-FDG PET/CT scanning for monitoring therapeutic response to antimicrobials in experimental Staphylococcus aureus osteomyelitis.

Methods

A total of 22 rabbits were studied. In 20 animals, the right tibia was inoculated intraoperatively with S. aureus. Two control animals were inoculated with normal saline. A needle was placed in the tibia as a foreign body. Infection was allowed to develop for 21 days when 18F-FDG PET/CT was performed, the needle was removed, and bone specimens were cultured to confirm infection. Antimicrobial therapy with daptomycin was initiated in all successfully infected animals for 1, 3, or 6 weeks. Following completion of treatment, a second 18F-FDG PET/CT was performed, animals were euthanized, and infected tibias were harvested for quantitative cultures and histology. A positive scan was defined as 18F-FDG signal activity greater in the infected tibia than that of the contralateral non-infected control tibia. Therapeutic response was measured by the change of 18F-FDG signal activity in the infected tibia.

Results

All successfully infected animals (n = 14), with microbiologically and/or histologically confirmed osteomyelitis, had positive 18F-FDG PET/CT scans, while the two control animals had negative scans despite the presence of the foreign body [mean maximum standardized uptake value (SUVmax) (±SD) values 2.96 (±0.80) vs. 1 (±1.10), respectively, P = 0.04]. In the 14 successfully infected animals, the mean SUVmax was significantly higher in the infected compared to the uninfected tibia (P < 0.0001). A SUVmax of 1.4, when used as a cutoff for infection, yielded a diagnostic accuracy of 93 %. At the end of treatment, successfully treated animals and saline controls had a negative 18F-FDG PET/CT scan (n = 4), while animals with persistent infection despite treatment (n = 12) had a positive 18F-FDG PET/CT scan (SUVmax 1.0–3.0) (p < 0.001). SUVmax values were significantly reduced after 42 days of treatment from 3.15 ± 0.5 (day 7) to 1.71 ± 0.37 (day 42) (p = 0.05).

Conclusions

18F-FDG PET/CT scan is a sensitive and specific tool in therapeutic monitoring of experimental foreign-body osteomyelitis.

Keywords

18F-FDG PET/CTExperimental osteomyelitis Staphylococcus aureus Daptomycin

Introduction

Prosthetic joint infection (PJI) remains one of the most dreadful complications of prosthetic joint implantation. As clinical signs and symptoms of PJI are usually non-specific, indolent, and vague, the diagnosis can be difficult even when accompanied by serologic, conventional radiographic, and microbiologic diagnostic tests [1, 2]. Plain radiographs are not helpful as they lack both sensitivity and specificity [3]. Computed tomography (CT) and magnetic resonance imaging (MRI) are limited by hardware-induced artifacts [13]. Functional imaging modalities have been extensively studied and applied for the diagnosis of PJI [4]. Yet, their diagnostic performance is not satisfactory and their routine use is not recommended [5]. Fluorine-18-fluoro-2-deoxy-d-glucose positron emission tomography combined with computed tomography (18F-FDG PET/CT) scan is a cutting-edge functional imaging as it provides images with higher resolution with concomitant anatomical information. 18F-FDG PET/CT has been reported in as a diagnostic imaging modality tor detection of PJIs [2, 4, 613]; however, little is known about its potential role for monitoring of response to antimicrobial therapy of osteomyelitis and PJI.

The management of PJI often necessitates a two-stage exchange procedure, i.e., removal of the infected prosthesis, prolonged courses of antimicrobial therapy, and re-implantation after the clearance of infection [14, 15]. One unresolved issue is the optimal time for re-implantation, because if infection reoccurs after a two-stage exchange has been accomplished, the success rate with a second two-stage exchange attempt may be lower than with the first attempt [15]. Currently, there are no diagnostic tools for monitoring the response to antimicrobial therapy and reliably exclude persistent joint infection, since clinical assessment, conventional imaging modalities, and laboratory tests may not be accurate [15]. 18F-FDG PET/CT scanning has the potential to provide objective parameters in the form of imaging and standardized uptake value (SUV) signal strength for the monitoring of therapeutic response in osteomyelitis.

We therefore studied 18F-FDG PET/CT scanning for therapeutic monitoring in a rabbit model of Staphylococcus aureus experimental foreign-body osteomyelitis. The experiments were designed to assess 18F-FDG PET/CT scan monitoring the success of antimicrobial therapy in eradicating bone infection after removal of the foreign body. To our knowledge, this is the first study of 18F-FDG PET/CT scanning in therapeutic monitoring of systemic antibacterial treatment of experimental S. aureus osteomyelitis.

Methods

The study was performed in the animal facility of the Center for Experimental Surgery of the Biomedical Research Foundation of the Academy of Athens. The facility is registered as a “breeding” and “experimental” facility according to the Greek Presidential Decree 160/91, on the protection of animal used for scientific purposes. The Veterinary Service of the Prefecture of Athens approved the protocol.

Study animals

A total of 22 male New Zealand white rabbits at the age of 4 months old and a body weight between 3.0 and 3.5 kg were used in this study. The animals were purchased from a registered rabbit farm (Farma Trompetas, Megara, Attiki, Greece) and reported to be free of bacterial and protozoal pathogens.

Each rabbit was housed individually in a single cage in a stainless steel rabbit cage rack (Tecniplast, Buguggiate, Italy) in a room temperature of 21 ± 2 °C, a relative humidity of 50 ± 5 %, and with a 12:12-h light-to-dark cycle. The rabbits were fed ad libitum with a prepackaged certified fiber rabbit chow (12C, Pezzulo, Italy) and had unlimited access to water via an automatic watering system. Before surgery, all rabbits were acclimated to their new environment for a period of 5 days.

Study protocol

The animal model and experimental design recapitulate the management of human PJI, including diagnosis of infection, removal of infected prosthesis, prolonged treatment with antibacterial agents, and assessment for clearance of infection before re-implantation (Fig. 1). A modified version of the tibial osteomyelitis model of Norden [16, 17] was used, in which the medullary cavity of the tibia was inoculated with methicillin-susceptible S. aureus, and a 25-gauge needle was inserted into the tibia and served as a foreign body, in both infected animals and controls. Control animals were inoculated with normal saline. Infection was allowed to develop for 21 days, and then an 18F-FDG PET/CT was performed, and blood cultures were taken. At this time point, all the animals, infected and controls, underwent a second stage surgery where the defect area was exposed, the needle was removed, the wound was debrided, and swab specimens and bone fragments taken with a curette were cultured to confirm the presence of infection. A bone culture yielding >104 colony-forming unit (cfu)/ml of the initially inoculated S. aureus strain was interpreted as established osteomyelitis.
Fig. 1

Flow chart of our animal model of experimental foreign-body osteomyelitis

Immediately after the second operation, antimicrobial treatment with daptomycin (4 mg/kg every 12 h subcutaneous) was initiated in all successfully infected animals. This dosage provides comparable pharmacokinetics in rabbits and humans and has been previously studied in experimental non-prosthetic S. aureus osteomyelitis, where it achieved bone levels exceeding that of plasma [1820]. The rabbits were allocated to receive treatment for 1, 3, or 6 weeks, in order to assess the correlation of 18F-FDG uptake with the gradual resolution of infection at different treatment time points. Following completion of the treatment, animals underwent a second evaluation including 18F-FDG PET/CT and blood cultures. Then, rabbits were euthanized and infected tibias were harvested for quantitative microbiological cultures and histology. A bone infection was considered as cured when at the end of treatment bone cultures were negative for pathogens and histology was negative for findings of infection.

Bacterial inoculum

The methicillin-susceptible S. aureus ATCC 29213 strain (American Type Culture collection, Manassas, VA, USA) was used for the preparation of the bacterial inoculum. The isolate was grown overnight in Tryptic Soy Broth (TSB) (Bioprepare, 19001, Keratea, Greece), washed three times in ice-cold sterile buffered salt solution, and adjusted to a bacterial suspension equivalent to 0.5 of the McFarland scale, measured at 600 nm (approximately 1.5 × 108 cfu/ml).

Technique of infection

The animals were anesthetized through the administration of an intra-muscular injection of ketamine (35 mg/kg, Imalgene 1000; Merial, Lyon, France) and xylazine (5 mg/kg Rompun; Bayer Animal Health GmbH, Leverkusen, Germany). The animals were intubated and connected to a veterinary ventilator (MDS Matrx Model 2000; Hallowell EMC, Pittsfield, MA, USA). Anesthesia was maintained with the administration of 1 minimum alveolar concentration (MAC) isoflurane (1.7–2 %, Forenium, Abbott, Abbot Park, IL, USA). Electrocardiography (DASH 2000 Pro, GE Healthcare, Milwaukee, WI, USA), vital signs, and oxygen saturation were monitored throughout the surgical procedure through appropriate electrodes, a pulse oximeter, and a rectal temperature probe (9-F, Mon-a-Therm; Mallinckrodt, St Louis, MI, USA).

Surgery was performed using standard aseptic techniques with one operator performing all procedures. A 2-cm incision was made in the skin 2.5 cm below the right knee joint, which exposed the medial cortex of the tibial metaphysis. A cortical defect was made with a 2-mm drill bit, and 0.1 ml (approximately 1.5 × 107 cfu) of the prepared bacterial suspension was instilled. A 25-gauge needle was placed through the hole and served as a foreign body, and the hub of the needle was broken off. Finally, the drilling hole was plugged with sterile bone wax to prevent bacterial leakage. The surgical field was lavaged with 50 ml of sterile saline water before wound closure in layers. The wound was cleaned using sterile saline water, and no sealing wound coverage was used. In control animals, a cortical defect of equal size was drilled but 0.1 ml of sterile saline water was inoculated. Further steps were similar as in the infectious animal group, up to wound closure and cleaning with sterile saline water. Then, neomycin sulfate spray (Pulvo 47, Abott Laboratories, Hellas) was applied (manufacturer details), and a single dose of cefuroxime sodium (25 mg/kg, Zinacef, GlaxoSmithKline, UK) was given IM postoperatively. Animals returned to their cages and given carprofen (4 mg/kg, Rimadyl, Pfizer, UK) analgesia as needed every 12 h.

18F-FDG PET/CT imaging

18F-FDG PET/CT scans were obtained for each animal at day 21 after the induction of osteomyelitis, as well as at the end of treatment, just before euthanasia (Fig. 1). The animals were not fed for at least 6 h prior to tracer injection. Each animal was scanned 30 min after the intravenous administration of 74 MBq (2 mCi) of 18F-FDG in the ear artery. Scanning was performed using a combined 18F-FDG PET/CT scanner (Siemens Biograph 6, high-resolution PET/CT, Knoxville, TN, USA). The acquisition time was 10 min per bed position for a total of two bed positions (20 min total acquisition time). The CT data were used for attenuation correction, and images were reconstructed using a standard ordered-subset expectation maximization (OSEM) algorithm. CT images were acquired with 85 mA, 130 KV, axial slice thickness of 3.0 mm, and table feed rotation of 10.0 mm per rotation. Data were corrected for dead time, decay, and photon attenuation. The image reconstruction matrix was 256 × 256. Fusion of the PET and CT images was performed. Every 18F-FDG PET/CT scan was assessed by visual inspection by two experienced nuclear medicine physicians blinded to the presence or not of osteomyelitis or to the timing of the scan as far as treatment was concerned. In case of disagreement, a third experienced nuclear medicine physician assessed the images and a consensus was achieved. An 18F-FDG PET/CT scan was considered as positive when visual inspection showed increased activity in the area of the inoculation compared to the adjacent normal bone or to the contralateral tibia. Measurements of tracer uptake were expressed as the maximum standardized uptake value (SUVmax) in the region of operated left tibia. Comparative measurements were made for each animal (expressed as SUVmax) in the corresponding region of the contralateral intact right tibia.

Microbiological analysis

Tissue specimens were collected in TSB (Bioprepare, Keratea, Greece) and homogenized using a Potter-Elvehjem PTFE tissue grinder (Sigma-Aldrich GmbH, 82024, Germany). Swabs were diluted in 0.5 ml TSB (Bioprepare, Keratea, Greece) and vortexed for 10 s. Quantitative cultures from the tissue homogenizations and the swab dilutions were performed on Columbia agar plates supplemented with 5 % horse blood (Bioprepare, Keratea, Greece) and incubated for 48 h in 5 % CO2 conditions. Any bacterial growth that was detected was sub-cultured and identified as the original inoculum based on common phenotypic and susceptibility testing patterns.

Histopathology

Separate cancellous bone particles harvested on sacrifice were fixed in neutral buffered formalin, embedded in paraffin wax, and sectioned and stained with hematoxylin and eosin. Tissues were examined for the presence of abscesses, type of inflammatory cells, and osseous injury.

Statistical analysis

In order to determine whether the mean SUVmax was different between the left (infected) and right (normal) upper tibial metaphysis of the animals, the null hypothesis was that the mean SUVmax was the same between the two sides. Differences in SUV signals between normal and infected areas of the same animal were analyzed paired t test. The receiver operating characteristic (ROC) analysis was used to define the cutoff SUVmax value for infection. Differences in therapeutic response as measured by the intensity of SUV signal were assessed between days 7 and 42 unpaired by t test. Comparisons of differences in proportions were analyzed by Fisher’s exact test. Values were expressed as mean ± SD, and statistical significance was defined as P ≤ 0.05.

Results

Establishment of infection and imaging findings on day 21 after inoculation

A total of 22 animals were studied; 20 animals received an intramedullary inoculum of S. aureus suspension, and two control animals received sterile saline. On day 21 after inoculation, all 22 rabbits underwent an 18F-FDG PET/CT scan followed by a second stage surgery, where swab specimens and bone samples were taken for laboratory studies. Swab and bone cultures established the presence of osteomyelitis, due to the inoculated strain of S. aureus in 14 animals, while the inoculated pathogen was not isolated in four animals (two controls and two animals inoculated with S. aureus). In four animals, the bone cultures grew pathogens other than the inoculated S. aureus strain, notably Staphylococcus epidermidis, probably due to contamination. All animals with failure to establish infection (n = 2) or contamination (n = 4) were excluded from the study resulting in a control group of 2 animals and an infection group of 14 animals (Fig. 1). In all animals, blood cultures taken on day 21 were negative for pathogens.

All 14 animals with established infection had a positive 18F-FDG PET/CT scan with SUVmax values ranging from 0.9 to 4.8 (Tables 1 and 2). The two animals in the control group had a negative 18F-FDG PET/CT scan, despite the presence of the foreign body. The mean SUVmax ratios were 1 (SD 1.10) and 2.96 (SD 0.80) for the control and osteomyelitis animal group, respectively (P = 0.04) (Fig. 2). In the 14 successfully infected animals, the mean SUVmax was found to be significantly higher in the infected tibia compared to the contralateral non-infected tibial metaphysis (t value 5.59, P value of 9 × 10−5) and the null hypothesis was rejected.
Table 1

Bone infection, treatment, and 18F-FDG PET/CT scan findings in rabbit model of S. aureus osteomyelitis

Animal number

Day 21

Day 0

Tx

Duration of treatment (weeks)

Day 7 of treatment/follow-up

Day 14 of treatment/follow-up

Day 21 of treatment/follow-up

Day 42 of treatment/follow-up

Bone infection at the end of treatment/follow-up

Inoculum

Bone infection

PET/CT (SUVmax)

 

PET/CT (SUVmax)

PET/CT (SUVmax)

PET/CT (SUVmax)

PET/CT (SUVmax)

706

Saline

No

Neg

No

Neg

Neg

No

693

Saline

No

Neg

No

Neg

Neg

No

700

S. aureus

No

Neg

No

701

S. aureus

No

Neg

No

698

S. aureus

Yes

Pos (2.6)

Yes

1

Pos (3.9)

Yes

699

S. aureus

Yes

Pos (4.1)

Yes

1

Pos (4.8)

Yes

702

S. aureus

Yes

Pos (3.2)

Yes

1

Pos (5.3)

Yes

703

S. aureus

Yes

Pos (2.6)

Yes

1

Pos (2.3)

Yes

707

S. aureus

Yes

Pos (1.7)

Yes

1

Pos (2.0)

Yes

695

S. aureus

Yes

Pos (1.8)

Yes

3

Pos (3.9)

Yes

694

S. aureus

Yes

Pos (3.5)

Yes

3

Pos (1.8)

Yes

692

S. aureus

Yes

Pos (1.4)

Yes

3

Pos (1.5)

Pos (1.6)

Neg (0.8)

No

704

S. aureus

Yes

Pos (1.9)

Yes

3

Pos (3.6)

Pos (3.8)

Yes

705

S. aureus

Yes

Pos (2.0)

Yes

3

Pos (1.8)

Pos (1.9)

Yes

708

S. aureus

Yes

Pos (3.4)

Yes

6

Pos (1.6)

Yes

709

S. aureus

Yes

Pos (2.5)

Yes

6

Pos (1.8)

Yes

716

S. aureus

Yes

Pos (4.8)

Yes

6

Neg (0.8)

No

718

S. aureus

Yes

Pos (0.9)

Yes

6

Pos (1.7)

Pos (2.8)

Pos (2.6)

Yes

Tx treatment, SUVmax maximum standardized uptake value, Pos positive, Neg negative

Table 2

SUVmax values from PET images in 14 successfully infected animals with S. aureus osteomyelitis

18F-FDG PET/CT scan

Number of animals

Average SUVmax

Maximum SUVmax

Minimum SUVmax

Left tibia

Right tibia

Left tibia

Right tibia

Left tibia

Right tibia

21 days post-inoculation, no treatment

14

2.6

1.1

4.8

1.4

0.9

0.7

7 days of treatment

8

3.2

1.2

5.3

1.4

1.5

0.9

14 days of treatment

2

1.6

1.0

1.7

1.1

1.6

0.8

21 days of treatment

6

2.5

1.0

3.9

1.4

0.8

0.8

42 days of treatment

4

1.7

0.8

2.6

0.8

0.8

0.8

SUVmax maximum standardized uptake value

Fig. 2

SUVmax values at day 21 after inoculation of S. aureus (n = 14) or normal saline (n = 2) in the tibia of the animals (**P < 0.05)

Figure 3 shows the distribution of the SUVmax values for the infected (left) and the normal site (right) of the 14 animals calculated from the first 18F-FDG PET/CT scan in the series. ROC analysis showed an SUVmax value of 1.4 as a cutoff value for infection with an accuracy of 93 % as well as a clear demarcation between infected and normal sites.
Fig. 3

The distribution of the SUVmax values for the infected (DO) and the normal contralateral tibia (right) of the 14 animals calculated from the first 18F-FDG PET/CT scan in the series

Antimicrobial treatment and follow-up studies (Table 1)

All animals with established osteomyelitis (n = 14) were treated with daptomycin for 2 weeks (five animals), 3 weeks (five animals), or 6 weeks (four animals). All animals survived until the end of the treatment period, when a second 18F-FDG PET/CT scan was performed. A positive 18F-FDG PET/CT scan was observed in all five animals treated for 1 week; four of the five animals treated for 3 weeks; and three of the four animals treated for 6 weeks (Figs. 4 and 5). In total, at the end of the treatment, 12 animals had a positive 18F-FDG PET/CT scan (SUVmax 1.0–3.0) and 2 animals had a negative 18F-FDG PET/CT scan.
Fig. 4

18F-FDG PET/CT scan images of a successfully treated rabbit with experimental tibial staphylococcal osteomyelitis. Sagittal images of the tibia of a rabbit demonstrating (top) increased tracer uptake (SUVmax = 4.8) at the area of osteomyelitis in the upper third of the tibia extending to the adjacent soft tissues (arrow) before the initiation of treatment and (bottom) physiologic tracer activity in the tibia of the same rabbit after 6 weeks of treatment with daptomycin. The animal was euthanized immediately after the 18F-FDG PET/CT scan, and bone cultures and histology were negative for infection. Note: On the left are the PET images and on the right the fused PET/CT images

Fig. 5

18F-FDG PET/CT scan images of an unsuccessfully treated animal with experimental staphylococcal tibial osteomyelitis. Sagittal images of the tibia of a rabbit demonstrating (top) increased tracer uptake (SUVmax = 3.6) with central photopenia at the area of osteomyelitis in the upper third of the tibia extending to the adjacent soft tissues (dense arrow) after 1 week of treatment and (bottom) persistent tracer activity (SUVmax = 3.8) in the tibia of the same rabbit (hollow arrow) after 3 weeks of treatment. The animal was euthanized immediately after the second 18F-FDG PET/CT scan, and both bone cultures and histology showed active infection. Note: On the left are the PET images and on the right the fused PET/CT images

Effect of treatment on SUVmax values

Tables 1 and 2 demonstrate the SUVmax before and after treatment. Three weeks after the inoculation of S. aureus and before the initiation of antimicrobial treatment, the mean SUVmax value of the 14 animals that were successfully infected was 2.6. The mean SUVmax value was 3.66 in eight animals treated for 1 week, 2.85 in six animals treated for 3 weeks, and 2.0 in four animals treated for 6 weeks (P < 0.05) (Fig. 6). At the end of the treatment, successfully treated animals and saline controls had a negative 18F-FDG PET/CT scan (n = 4), while animals with persistent infection despite treatment (n = 12) had a positive 18F-FDG PET/CT scan (SUVmax 1.0–3.0) (p < 0.001).
Fig. 6

Effect of antimicrobial treatment on the SUVmax values. Initiation of antimicrobial treatment resulted in statistically significant (p = 0.03) reduction in the SUVmax values (left panel). The reduction was prominent at 42 days of treatment (right panel)

Correlation between SUVmax values and quantitative cultures

After the 18F-FDG PET/CT scans, animals were euthanized, infected tibias were harvested, and swabs, as well as specimens of cancellous bone, were sampled under sterile conditions for laboratory studies. The inoculated strain of S. aureus was cultured at >104 cfu/ml or cfu/gram of bone, from all harvested bones of the 12 animals with a positive 18F-FDG PET/CT scan.

Histology revealed active osteomyelitis in all specimens with positive cultures ≥104 cfu/ml. These findings were interpreted as treatment failure. In contrast, the two successfully treated animals with negative 18F-FDG PET/CT scans and the two saline non-infected controls had negative bone and/or swab cultures and no histological evidence of active infection.

Discussion

This study found that 18F-FDG PET/CT scan is a sensitive and specific tool in therapeutic monitoring of experimental foreign-body osteomyelitis. The study also found that 18F-FDG PET/CT scan accurately distinguishes between a bone with a metal implant and infection from a bone with a metal implant but without infection. All successfully infected animals, with microbiologically and/or histologically confirmed foreign-body osteomyelitis, had positive 18F-FDG PET/CT scan, while all animals without infection had negative 18F-FDG PET/CT scan, despite the presence of the foreign body. In all successfully infected animals, 18F-FDG PET/CT scan demonstrated increased tracer uptake in the infected area, compared to the control group (P < 0.05). In addition, compared to the contralateral not infected tibia, the SUVmax was significantly higher in the infected one (P < 0.05). We also found that a SUVmax cutoff value of 1.4 was able to differentiate foreign-body osteomyelitis from normal bone, with an accuracy of 93 %.

The rabbit model of S. aureus osteomyelitis has been used to explore the diagnostic efficacy of 18F-FDG PET scan. Lankier et al. showed that foreign-body-associated infection in the rabbit tibia caused by S. epidermidis results in lower 18F-FDG uptake than pyogenic S. aureus infections [21]. Researchers have shown by using a rabbit model of S. aureus osteomyelitis that bone healing was associated with a temporary increase in 18F-FDG uptake at 3 weeks, but it returned to normal by 6 weeks [22]. In contrast, localized osteomyelitis resulted in a significantly higher, continuous uptake of 18F-FDG. Similar results have been reported in a clinical study [9]. In clinical practice, 18F-FDG PET has demonstrated promising results for diagnosis of osteomyelitis. Nevertheless, its role in diagnosing PJI is less documented, as in a recent review sensitivity varied widely from 28 to 91 % and specificity from 9 to 97 % [6]. The discrepancy between the promising results in animal models and the wide variation in 18F-FDG PET/CT performance in the diagnosis of PJI in clinical studies might reflect the lack of criteria to interpret the 18F-FDG PET/CT scan findings suggestive of infection.

The main objective of our study was to establish the accuracy of 18F-FDG PET/CT scan for monitoring the therapeutic response of bacterial osteomyelitis to antimicrobial therapy, after removing the foreign body. We have shown in our animal model that the SUVmax values were significantly lower after 42 days of treatment. Additionally, all 12 animals with documented persistent infection after completion of antimicrobial therapy had a positive 18F-FDG PET/CT scan, while in 2 animals where the infection had been eradicated, the 18F-FDG PET/CT scans were negative. The clinical implications of these findings are obvious as in clinical practice, the existing diagnostic modalities, such as clinical assessment, imaging findings, or serology, cannot accurately exclude persistent joint infection after resection arthroplasty [14, 15]. Re-implantation without previous clearance of infection might compromise the efficacy of the two-stage exchange procedure for the treatment of PJI. Our experimental data suggest that in clinical practice, 18F-FDG PET/CT scan might have a role in excluding persisting infection before re-implantation.

Our study has several limitations. One isolate of S. aureus was used. While other isolates of S. aureus may have a different pro-inflammatory response, this is unlikely. A baseline and end of therapy scan were performed with no intervening scans; however, the study design does allow for understanding different groups of animals at different time points. A single dosage of daptomycin was used. Although this study was not designed to determine the optimal dosage and duration of daptomycin for treatment of foreign-body osteomyelitis, it establishes a conceptual framework by which a larger study may be conducted. The use of multiple experimental animals, sacrificed at pre-defined time points, and the direct documentation or exclusion of infection by means of both bone culture and histology establishes a correlation between therapeutic response and 18F-FDG PET/CT imaging technology.

Conclusions

In summary, 18F-FDG PET/CT imaging technology is a sensitive and specific tool in the diagnosis of experimental foreign-body osteomyelitis and in monitoring the therapeutic response of experimental osteomyelitis after removal of the foreign body. These data can be used in the development of a prospective clinical trial in the use in the diagnosis and therapeutic monitoring of human PJI with the use of 18F-FDG PET/CT scan.

Abbreviations

18F-FDG PET/CT: 

fluorine-18 fluoro-2-deoxy-d-glucose positron emission tomography combined with computed tomography

MRI: 

magnetic resonance imaging

PJI: 

prosthetic joint infection

SUVmax: 

maximum standardized uptake value

Declarations

Acknowledgments

The authors would like to thank Maria Kallergi, PhD, and Dr. Dimitrios Ziogas, MD, for their assistance in the statistical analysis of the data. Dr. Nikolaos V. Sipsas acknowledges support from the Special Account for Research Funds (ELKE) of the National and Kapodistrian University of Athens, Greece. Dr. Thomas J. Walsh is supported in part as a scholar of the Sharp Family Foundation in Pediatric Infectious Diseases and as a scholar in Emerging Infectious Diseases from the Save Our Sick Kids Foundation.

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Second Department of Radiology, Medical School, National and Kapodistrian University of Athens
(2)
Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens
(3)
Third Department of Orthopedics, Medical School, National and Kapodistrian University of Athens
(4)
Department of Pathology, Medical School, National and Kapodistrian University of Athens
(5)
Department of Microbiology, Medical School, National and Kapodistrian University of Athens
(6)
PET/CT Section, Foundation for Biomedical Research of the Academy of Athens
(7)
Center for Experimental Surgery, Foundation for Biomedical Research of the Academy of Athens
(8)
Departments of Medicine, Pediatrics, and Microbiology & Immunology, Weill Cornell Medical Center of Cornell University

References

  1. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–54.View ArticlePubMedGoogle Scholar
  2. Love C, Marwin SE, Palestro CJ. Nuclear medicine and the infected joint replacement. Semin Nucl Med. 2009;39:66–78.View ArticlePubMedGoogle Scholar
  3. Adesanya O, Sprowson A, Masters J, Hutchinson C. Review of the role of dynamic 18F-NaF PET in diagnosing and distinguishing between septic and aseptic loosening in hip prosthesis. J Orthop Surg Res. 2015;10:5.PubMed CentralView ArticlePubMedGoogle Scholar
  4. Gemmel F, Van den Wyngaert H, Love C, Welling MM, Gemmel P, Palestro CJ. Prosthetic joint infections: radionuclide state-of-the-art imaging. Eur J Nucl Med Mol Imaging. 2012;39:892–909.View ArticlePubMedGoogle Scholar
  5. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1–e25.View ArticlePubMedGoogle Scholar
  6. van der Bruggen W, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJ. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med. 2010;40:3–15.View ArticlePubMedGoogle Scholar
  7. Love C, Marwin SE, Tomas MB, Krauss ES, Tronco GG, Bhargava KK, et al. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection fluorine-18 FDG and indium-111-labeled leukocyte/technetium-99m-sulfur colloid marrow imaging. J Nucl Med. 2004;45:1864–71.PubMedGoogle Scholar
  8. Pill SG, Parvizi J, Tang PH, Garino JP, Nelson C, Zhuang H, et al. Comparison of fluorodeoxyglucose positron emission tomography and (111) indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip. J Arthroplasty. 2006;21:91–7.View ArticlePubMedGoogle Scholar
  9. Zhuang H, Duarte PS, Pourdehnad M, Maes A, Van Acker F, Shnier D, et al. The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nuc Med. 2001;42:44–8.Google Scholar
  10. Chacko TK, Zhuang H, Stevenson K, Moussavian B, Alavi A. The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses. Nucl Med Commun. 2002;23:851–5.View ArticlePubMedGoogle Scholar
  11. Reinartz P, Mumme T, Hermanns B, Cremerius U, Wirtz DC, Schaefer WM, et al. Radionuclide imaging of the painful hip arthroplasty. Positron-emission tomography versus triplephase bone scanning. J Bone Joint Surg [Br]. 2005;87:465–70.View ArticleGoogle Scholar
  12. Manthey N, Reinhard P, Moog F, Knesewitsch P, Hahn K, Tatsch K. The use of [18F] fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses. Nucl Med Commun. 2002;23:645–53.View ArticlePubMedGoogle Scholar
  13. Stumpe KD, Notzli HP, Zanetti M, Kamel EM, Hany TF, Görres GW, et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology. 2004;231:333–41.View ArticlePubMedGoogle Scholar
  14. Kusuma SK, Ward J, Jacofsky M, Sporer SM, Della Valle CJ. What is the role of serological testing between stages of two-stage reconstruction of the infected prosthetic knee? Clin Orthop Relat Res. 2011;469:1002–8.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Bejon P, Berendt A, Atkins BL, Green N, Parry H, Masters S, et al. Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology. J Antimicrob Chemother. 2010;65:569–75.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Norden CW. Experimental osteomyelitis. I. A description of the model. J Infect Dis. 1970;122:410–8.View ArticlePubMedGoogle Scholar
  17. Smeltzer MS, Thomas JR, Hickmon SG, Skinner RA, Nelson CL, Griffith D, et al. Characterization of a rabbit model of staphylococcal osteomyelitis. J Orthop Res. 1997;15:414–21.View ArticlePubMedGoogle Scholar
  18. Falagas ME, Giannopoulou KP, Ntziora F, Papagelopoulos PJ. Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence. Int J Antimicrob Agents. 2007;30:202–9.View ArticlePubMedGoogle Scholar
  19. Mader JT, Adams K. Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits. Antimicrob Agents Chemother. 1989;33:689–92.PubMed CentralView ArticlePubMedGoogle Scholar
  20. Dvorchik BH, Brazier D, DeBruin MF, Arbeit RD. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother. 2003;47:1318–23.PubMed CentralView ArticlePubMedGoogle Scholar
  21. Lankinen P, Lehtimäki K, Hakanen AJ, Roivainen A, Aro HT. A comparative 18F-FDG PET/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia. EJNMMI Res. 2012;2:41.PubMed CentralView ArticlePubMedGoogle Scholar
  22. Koort JK, Mäkinen TJ, Knuuti J, Jalava J, Aro HT. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. J Nucl Med. 2004;45:1406–11.PubMedGoogle Scholar

Copyright

© Chatziioannou et al. 2015

Advertisement